Description
Recombinant monoclonal antibody to ICOS. Manufactured using AbAb’s Recombinant Platform with variable regions (i.e. specificity) from the hybridoma 7E.17G9.
Target
ICOS
Target Alias Names
CD278, AILIM, CVID1, inducible T-cell co-stimulator, inducible T-cell costimulator, 7E.17G9.G1.G7
Isotype/Mimetic
IgG2b
Animal-Derived Biomaterials Used
No
Sequence Available
No
Original Discovery Method
recombinantly reformatted hybridoma (from pre-2020 immunisation)
Original Discovery Information Provided On Datasheet
Yes
Antibody/Binder Origins
Animal-dependent discovery (in vitro display, OR immunisation pre-2020), In vitro recombinant expression